Jeffrey D. Dunn
6 Podcast Episodes
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
This webcast examines system-level strategies to increase the achievement of adequate glycemic control, including patien... Read more
1 Nov 2019
•
41mins
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
The Benefits and Cost-Effectiveness of SGLT2 Inhibitors in T2DM Care - Susan Cornell, PharmD, CDE, FAPhA, FAADE and Jeffrey D. Dunn, PharmD, MBA
This webcast examines system-level strategies to increase the achievement of adequate glycemic control, including patien... Read more
1 Nov 2019
•
41mins
Similar People
Sonia Friedman
Robert Sidbury
Jonathan Kay
Richard Kim
Stanley Cohen
Matt S
Atopic Dermatitis
Axel Grothey
Tanios Bekaii-Saab
Ghassan Abou-Alfa
Heinz-Josef Lenz
Rakesh Jain
Josep Tabernero
Jean-Yves Douillard
John Cooper
Evaluating Novel Targeted Therapies in RA: Clinical and Cost Considerations for Achieving Treatment Goals - Stanley Cohen, MD and Jeffrey D. Dunn, PharmD, MBA
Evaluating Novel Targeted Therapies in RA: Clinical and Cost Considerations for Achieving Treatment Goals - Stanley Cohen, MD and Jeffrey D. Dunn, PharmD, MBA
This webcast discusses the latest clinical data on current and emerging RA treatments and outlines strategies to reduce ... Read more
30 Sep 2019
•
1hr 3mins
Evaluating Novel Targeted Therapies in RA: Clinical and Cost Considerations for Achieving Treatment Goals - Stanley Cohen, MD and Jeffrey D. Dunn, PharmD, MBA
Evaluating Novel Targeted Therapies in RA: Clinical and Cost Considerations for Achieving Treatment Goals - Stanley Cohen, MD and Jeffrey D. Dunn, PharmD, MBA
This webcast discusses the latest clinical data on current and emerging RA treatments and outlines strategies to reduce ... Read more
30 Sep 2019
•
1hr 3mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Advancing Multiple Sclerosis Treatment and Outcomes: Navigating Access, Adherence, and Site of Care Obstacles - Jeffrey D. Dunn, PharmD, MBA and Clyde E. Markowitz, MD
Advancing Multiple Sclerosis Treatment and Outcomes: Navigating Access, Adherence, and Site of Care Obstacles - Jeffrey D. Dunn, PharmD, MBA and Clyde E. Markowitz, MD
Hear about access, adherence, and site of care issues that hinder optimal MS treatment, and learn best practices to inte... Read more
29 Apr 2019
•
1hr 2mins
Advancing Multiple Sclerosis Treatment and Outcomes: Navigating Access, Adherence, and Site of Care Obstacles - Jeffrey D. Dunn, PharmD, MBA and Clyde E. Markowitz, MD
Advancing Multiple Sclerosis Treatment and Outcomes: Navigating Access, Adherence, and Site of Care Obstacles - Jeffrey D. Dunn, PharmD, MBA and Clyde E. Markowitz, MD
Hear about access, adherence, and site of care issues that hinder optimal MS treatment, and learn best practices to inte... Read more
29 Apr 2019
•
1hr 2mins
